UK Markets closed
NIKKEI 225
26,547.05 +119.40 (+0.45%) HANG SENG
19,950.21 +51.44 (+0.26%) CRUDE OIL
112.86 +2.37 (+2.14%) GOLD FUTURES
1,812.90 +4.70 (+0.26%) DOW
32,153.43 -43.23 (-0.13%) BTC-GBP
23,950.64 -752.97 (-3.05%)
Illumina, Inc. (ILMN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:45PM EDT. Market open.
| Previous close | 233.56 |
| Open | 231.74 |
| Bid | 232.84 x 900 |
| Ask | 233.25 x 900 |
| Day's range | 229.45 - 237.11 |
| 52-week range | 208.35 - 526.00 |
| Volume | |
| Avg. volume | 942,435 |
| Market cap | 36.352B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 38.07 |
| EPS (TTM) | 6.11 |
| Earnings date | 25 Apr 2022 - 29 Apr 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 436.19 |
- Simply Wall St.
Is Illumina, Inc.'s (NASDAQ:ILMN) Recent Price Movement Underpinned By Its Weak Fundamentals?
With its stock down 31% over the past month, it is easy to disregard Illumina (NASDAQ:ILMN). We, however decided to...
- Reuters
Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case
A Delaware jury on Friday ordered Illumina Inc to pay more than $333 million to a U.S. unit of Chinese genomics company BGI Group after finding that Illumina's DNA-sequencing systems infringed two patents. The jury also said Illumina infringed the patents willfully, and that three patents it had accused BGI's Complete Genomics unit of infringing were invalid.
- Zacks
Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Down
Illumina (ILMN) ended the first quarter with better-than-expected earnings and revenues on strength in Core Illumina and the GRAIL businesses driving the top line.
© 2022 Yahoo. All rights reserved.
